for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

InterCure Ltd

INCR.TA

Latest Trade

354.40ILa

Change

-5.20(-1.45%)

Volume

246,282

Today's Range

350.00

 - 

365.00

52 Week Range

185.30

 - 

573.00

As of on the Tel Aviv Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
359.60
Open
357.00
Volume
246,282
3M AVG Volume
14.02
Today's High
365.00
Today's Low
350.00
52 Week High
573.00
52 Week Low
185.30
Shares Out (MIL)
118.08
Market Cap (MIL)
422.78
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Intercure's Canndoc Entered Into Strategic Partnership Agreement With Super-Pharm

Intercure Says Unit Canndoc Entered Strategic Distribution Agreement With Teva Pharmaceuticals Unit

Intercure Ltd Announces Resignation of Chief Executive Officer, Mr. Erez Gavish; Appoints Mr. Ronen Twito as Replacement-Complete Story

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About InterCure Ltd

InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in sympathetic outflow of the autonomous nervous system, one of the key underlining causes for cardiovascular disease, insomnia and multiple other conditions. The Company operates a marketing office in London and outsourced call centers and warehouses in the United States, the United Kingdom, Germany and Canada.

Industry

Medical Equipment & Supplies

Contact Info

Medinat HaYehudim 85

4676670

Israel

+972.7.32207002

Executive Leadership

Ehud Barak

Chairman of the Board

Alexander Rabinovitch

Chief Executive Officer, Director

Asher Zamir

Vice President - Finance

Yisrael Gewirtz

Internal Auditor

Avner Barak

Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
21.28
Price To Book (MRQ)
1.79
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
7.85
LT Debt To Equity (MRQ)
1.12
Return on Investment (TTM)
-31.40
Return on Equity (TTM)
-28.11

Latest News

Latest News

BRIEF-Intercure's Canndoc Entered Into Strategic Partnership Agreement With Super-Pharm

* INTERCURE LTD - ENTERED INTO STRATEGIC PARTNERSHIP AGREEMENT WITH SUPER-PHARM

InterCure gets Israel's first imported medical cannabis shipment

Canndoc, an Israeli producer of medical grade cannabis, on Sunday received a shipment of 250 kilos of dried whole cannabis flowers that it says will help alleviate a shortage in Israel.

Israel's Canndoc signs cannabis import-export deal with Tilray

Israel's InterCure Ltd said on Thursday its subsidiary Canndoc has signed a strategic cooperation agreement with Tilray Inc for the import and export of medical cannabis.

RPT-Israel likely to allow medical cannabis exports by year-end - senior MP

Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.

Israeli medical cannabis firm InterCure plans Nasdaq listing

Israel's InterCure <INCR.TA>, which recently entered the medical cannabis market, plans to list on Nasdaq by mid-2019, its controlling shareholder, Alex Rabinovitch, said on Thursday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up